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INTRODUCTION
Systemic lupus erythematosus (SLE) is a complex
disease that’s characterized by an autoantibody response
to nuclear and cytoplasmic antigens. The autoantibody
response is associated with the inflammatory cascades
and end-organ damage in the kidney, skin, brain and
other organs. Especially in the kidney, immune-complex
deposits of autoantibodies have been implicated as major
pathogenic mediators [1].
The diagnosis of SLE can be made by fulfilling the
revised criteria of the American College of Rheumatology
[2]. One of the laboratory hallmarks of SLE is the presence
of antinuclear antibodies (ANA) in the serum [3]. On the
other hand, a small subset of SLE patients with the typical
clinical findings of SLE was reported to have persistently
negative ANA tests. These patients were designated as
ANA-negative SLE and their clinical picture was notable
for the high incidence of photosensitive dermatitis and the
low incidence of nephritis and neuropsychiatric mani-
festations [4].
We report here on a case of an ANA-negative SLE
patient who presented with lupus nephritis. The other
serum autoantibodies, including anti-double stranded
DNA antibody (anti-dsDNA), anti-extractable nuclear
antigens antibodies and antiphosopholipid antibodies,
and the repeated ANA testing were all negative. 
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CASE REPORT
Systemic lupus erythematosus (SLE) is a typical autoimmune disease that’s characterized by various
autoantibodies to nuclear and cytoplasmic antigens. The presence of antinuclear antibodies (ANA) in serum is
generally considered a decisive diagnostic sign of SLE. However, a small subset of SLE patients who had the
typical clinical features of SLE was reported to show persistently negative ANA tests. Our report describes a 16-
yr-old female who presented with the clinical manifestations of SLE such as malar rash, photosensitivity, arthritis,
lymphopenia, pericarditis and proteinuria. The serum autoantibodies were all negative and renal biopsy showed
that the histopathological changes of immune complex mediated the focal segmental necrotizing
glomerulonephritis with crescent formation. She was treated with monthly pulse cyclophosphamide along with
corticosteroids. During the 2-yr follow-up period, the proteinuria was markedly decreased and all of the ANA and
anti-double stranded DNA antibody tests were negative. This case suggests that ANA may not be required in the
pathogenesis of lupus nephritis. (Korean J Intern Med 2009;24:76-79)
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A 16-yr-old female was admitted due to pain in multiple
joints she had experienced for a week and also for a skin
rash on her face and legs she had experienced for 2 days.
Her blood pressure was 119/74 mmHg, the pulse rate
115/min, the respiratory rate 20/min and the body
temperature 37.0˚C . She had a malar rash, photosen-
sitivity and a erythematous maculopapular rash on both
legs. There was active synovitis that involved her proximal
interphalangeal joints, metacarpophalangeal joints,
wrists, elbows, metatarsophalangeal joints, ankles and
knees. Her initial laboratory investigations showed a white
blood cell count of 9,830/mm
3 (lymphocyte 777/mm
3), a
hemoglobin level of 12.3 g/dL, a platelet count of
182,000/mm
3, the erythrocyte sedimentation rate was 24
mm/h and the C-reactive protein level was 1.63 mg/dL.
The levels of C3 and C4 were normal. She had no
proteinuria on urinalysis. Antinuclear antibody, anti-
dsDNA, anti-cardiolipin antibody, lupus anticoagulant,
anti-RNP antibody, anti-Sm antibody, anti-Ro antibody,
anti-La antibody and rheumatoid factor were all negative.
A skin biopsy was taken from an erythematous lesion on
her leg. The histopathology of the biopsy specimen showed
leukocytoclastic vasculitis without immune deposits. She
complained of chest pain on day 3 of admission. The chest
X-ray and electrocardiogram were normal, but an
echocardiogram showed a minimal pericardial effusion.
She was diagnosed as having ANA-negative SLE on the
basis of the malar rash, photosensitivity, arthritis,
lymphopenia and pericarditis. She was treated with
nonsteroidal antiinflammatory drugs, hydroxychloro-
quine, methotrexate and low dose corticosteroids. Most of
her symptoms were controlled and she was discharged on
the 11th day of admission.
One month later, she was readmitted with diffuse
abdominal pain she had experienced for 2 weeks.
Abdominal computed tomography demonstrated diffuse
bowel wall thickening in the cecum and terminal ileum
(Fig. 1). There was mild leukocytosis, but the blood urea
nitrogen and serum creatinine levels were normal. The
retests for ANA and anti-dsDNA were negative. A urine
examination showed 2+ proteinuria by a dipstick test and
the protein/creatinine ratio of a random urine test was
2.84 (800/282). Renal biopsy was performed and that
contained 15 glomeruli. Most of the glomeruli showed
slight expansion of the mesangial matrix with focal and
segmental mesangial cell proliferation (Fig. 2). Segmental
collapse and adhesion to Bowmann’s capsule was noted in
5 glomeruli. Immunofluorescent staining revealed 6
glomeruli that showed strong IgG deposits, mild IgA, C3
and fibrinogen deposits and minimal C1q deposits that
were mainly seen at the mesangium (Fig. 3A). The elec-
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Figure 1. Abdomen Computed Tomography. There are diffuse bowel
wall thickenings in the terminal ileum.
Figure 2. Renal biopsy. (A) Focal segmental necrotizing glomerulonephritis. Occasional karyorrhexis and fibrinoid necrosis are noted (H&E,
×400). (B) Small cellular crescent formation is noted in three glomeruli (PAS, ×400).
A Btron microscopic findings showed mesangial electron
dense deposits (Fig. 3B). The subendothelial electron dense
deposits were focal and segmental. No tubuloreticular
structure was present. Three of them showed a small
active cellular crescent.
ANA-negative lupus nephritis was considered and she
was treated by monthly pulse cyclophosphamide and
high-dose corticosteroids, and she showed persistently
improving proteinuria. During the 2-year follow-up
period, repeated tests for ANA and anti-dsDNA were all
negative. Currently, she has 1+ proteinuria by the dipstick
test and the protein/creatinine ratio of a random urine
test was 0.42 (58/137).
DISCUSSION
Systemic lupus erythematosus is a chronic inflam-
matory autoimmune disease that involves many different
organ systems, and this illness exhibits a wide spectrum of
clinical manifestations. The diagnosis of SLE depends on
the patient’s clinical and laboratory abnormalities [2].
Various kinds of autoantibodies are present in the sera of
SLE patients, and ANA is a diagnostic hallmark for SLE,
having a frequency of 95% or greater in SLE patients [5].
However, several investigators have reported that small
groups of patients with the clinical features of SLE have
negative tests for ANA. These patients appear to represent
1-5% of the SLE population. The age of onset and the female
predominance are the same for ANA-negative SLE as for
ANA-positive SLE [6]. ANA-negative SLE patients are
known to have a higher prevalence of anti-Ro antibody
and cutaneous manifestations, as well as a lower preva-
lence of both central nervous system and renal involve-
ment [4,7]. Maddison et al. described 66 SLE patients with
negative ANA, as was determined by indirect immuno-
fluorescence. They found serum antibodies to cytoplasmic
components; 62% of patients had anti-Ro antibody and
27% had anti-La antibody [4].
One explanation for the ANA-negative finding is
technical inaccuracy. McHardy et al. identified 38 adults
who had a high DNA-binding capacity, but negative
fluorescent ANA testing (with a rat liver substrate), and
the clinical diagnosis of SLE was established for these
patients [8]. In another study, the previously ANA-
negative finding, with using mouse liver substrate, in the
sera of patients with SLE or subacute cutaneous lupus
erythematosus was found to be anti-Ro antibody positive
by performing enzyme-linked immunosorbent assays [9].
Actually, the increasing use of human epithelial (HEp-2)
substrate has increased the sensitivity of ANA assays and
as a result, the perceived incidence of ANA-negative SLE
has decreased [8,10].
Another cause of ANA-negative findings is that ANA is
present, but its bound in the form of immune complexes.
This has been described in five patients with lupus nephri-
tis whose ANAs, which were primarily reactive with DNA,
were not detected in the serum by indirect immuno-
fluorescence until the ANAs were dissociated from cir-
culating immune complexes [11]. Loss of ANA through the
kidney in a patient with profuse proteinuria has been
reported as another possibility. In that case, the tests for
ANA became positive upon clinical recovery [12]. However,
most ANA-negative patients have persistently negative
tests for ANA after a long follow-up period. Technical
factors or prozone effects have been described as the
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Figure 3. Renal biopsy. (A) Immunofluorescence micrograph shows global, large mesangial deposits of IgG. There are sparce subendothelial deposits.
(B) Electron microscopy shows mesangial electron-dense deposits. Subendothelial electron-dense deposits are sparse and only focally present.
A Bpossible reasons for this [13].
Lupus nephritis is believed to be a consequence of the
deposition of immunoglobulins in the kidney, and the
predominant immunoglobulin isotype is IgG. Also, lupus
nephritis is frequently associated with ANA and anti-
dsDNA. On rare occassions, the serological markers may
be initially absent, but they become positive after some
time in most patients [14]. Gianviti et al. reported on three
patients aged 9, 8 and 10 years old, respectively, who
presented with a glomerulopathy suggestive of lupus
nephritis, but they were without clinical or serological
evidence of SLE [15]. All developed ANA and anti-dsDNA
at 5, 3 and 10 years, respectively, after their original pre-
sentation, but only one patient developed clinical symp-
toms of SLE in 6 years. Development of ANA and anti-
dsDNA secondary to the release of nuclear antigens into
the blood stream during hemodialysis treatment has been
reported in the literature. Ozdemir et al. described a 28-
yr-old female who was admitted with acute renal failure
following her fourth delivery [16]. The serum immuno-
logical markers were negative and renal biopsy showed
histopathological changes consistent with SLE as the
etiology of her nephritic syndrome. During the follow-up
period with administering immunosuppressive treatment,
the ANA became positive as the proteinuria declined. Yet
in our patient, the autoantibodies including ANA were
negative during the follow-up period, even though there
was strong IgG deposit in the glomeruli. There are several
possible explanations for this. First, the level of ANA in the
sera may be too low to detect by conventional clinical assays.
Second, our follow-up period may not have been long enough
for her to develop ANA. Finally, the renal damage in our
patient may have been mediated by autoantibodies that do
not react with ANA.
In conclusion, our patient fulfilled the ACR criteria,
including having a renal disorder without serologic
evidence of SLE at presentation. During the follow-up
period, the repeated ANA and anti-dsDNA tests were all
negative, irrespective of her improving proteinuria. Our
patient may be a very rare case of ANA-negative lupus
nephritis without seroconversion and this suggests that
ANA may not be required in the pathogenesis of lupus
nephritis.
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